Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...

The Trump administration's decision to pause enforcement of an anti-bribery law raised the specter that drugmakers could ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.

Goldman Sachs analyst warns 340B reforms could shift profits to biopharma, benefiting companies like Merck and Gilead. Proposed Medicaid cuts may create risks for biopharma, impacting drugs like ...

Industries showering Trump with cash included Big Oil, Big Tech, Big Pharma, Big Tobacco, Wall Street, crypto and private prison interests, and more. Many of the corporate donors are poised to win ...

Robert F Kennedy Jr. took Sen. Bernie Sanders to the woodshed during his confirmation hearing, confronting the Vermont lawmaker on Big Pharma campaign contributions. The explosive moment unfolded ...

Contentious hearings to consider Robert F. Kennedy Jr. to lead the Department of Health and Human Services this week have shined a spotlight on some of Washington’s most powerful lobbies.

Takeda-backed Ascentage Pharma Group (AAPG) (OTCPK:ASPHF), (OTCPK:AAPGV) which is developing treatments for blood cancer, has set terms for a $170M U.S. initial public offering. In an SEC filing ...

In the tough market conditions last year, investors and big pharma companies were more likely to place their bets on later, clinical-stage companies. But local biotech leaders see signs of change ...

“Big Data” in the form of billions of web pages is available to train large language models, and in the form of millions of transactions for specific products to train models that make personalized ...

The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...